LivaNova plc Stock
LivaNova plc Stock
The LivaNova plc price is unchanged compared to yesterday.
With 16 Buy predictions and not the single Sell prediction the community is currently very high on LivaNova plc.
As a result the target price of 57 € shows a slightly positive potential of 7.55% compared to the current price of 53.0 € for LivaNova plc.
Pros and Cons of LivaNova plc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of LivaNova plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| LivaNova plc | 0.000% | 0.000% | -2.752% | 18.304% | 19.369% | 3.922% | -2.752% |
| Icu Medical Inc. | - | 0.000% | -1.575% | -16.667% | -14.966% | -13.194% | -28.571% |
| Bio-Rad Labs Inc. A | 0.590% | 0.272% | -10.264% | -18.231% | -17.892% | -31.736% | -45.128% |
| Neogen Corp. | 0.820% | 0.820% | 18.269% | -48.750% | -48.750% | - | - |
Comments
LivaNova (NASDAQ:LIVN) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $81.00 price target on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Mizuho from $70.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Mizuho from $65.00 to $70.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
News
LivaNova to Announce Second-Quarter 2025 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2025 results on Wed., Aug. 6, 2025, at 1 p.m. London time (8 a.m
